Jennifer Furin

Also affiliated with Harvard Global Health Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis”.

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis

PLoS Medicine(2024)10.1371/journal.pmed.1004401

N/A

0.501DataRank · unranked

15 citations

Fayette Klaassen, Sedona Sweeney, Jennifer Furin, Molly F. Franke, Reza Yaesoubi +7 more

A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00436-0

N/A

0.315DataRank · unranked

4 citations

Isabelle R. Weir, Kimberly K. Scarsi, Alberto Mendoza‐Ticona, Samuel Pierre, Luke Hall +30 more

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis

Trials(2025)10.1186/s13063-025-08973-w

N/A

0.168DataRank · unranked

2 citations

Gustavo E. Velásquez, Russell R. Kempker, Marjorie Z. Imperial, Eric L. Nuermberger, Susan E. Dorman +22 more

The Impact of Tuberculosis on the Well-Being of Adolescents and Young Adults

Pathogens(2021)10.3390/pathogens10121591

N/A

0DataRank · unranked

43 citations

Leslie A. Enane, Graeme Hoddinott, Meredith B. Brooks, Virginia F. Byron, Jennifer Furin +4 more

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study

The Lancet Microbe(2021)10.1016/s2666-5247(21)00144-0

N/A

0DataRank · unranked

24 citations

Zubeida Salaam-Dreyer, Galo A. Goig, Mark P. Nicol, Fabrizio Menardo, Anzaan Dippenaar +12 more

Integrated Clinical and CT Based Artificial Intelligence Nomogram for Predicting Severity and Need for Ventilator Support in COVID-19 Patients: A Multi-Site Study

IEEE Journal of Biomedical and Health Informatics(2021)10.1109/jbhi.2021.3103389

N/A

0DataRank · unranked

20 citations

Kaustav Bera, Lei Yuan, Pranjal Vaidya, Mehdi Alilou, Jennifer Furin +8 more

The incalculable costs of tuberculosis

The Lancet Global Health(2021)10.1016/s2214-109x(21)00345-4

N/A

0DataRank · unranked

2 citations

Jennifer Furin, Helen Cox

Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods

PLOS Digital Health(2022)10.1371/journal.pdig.0000059

N/A

0DataRank · unranked

6 citations

Melanie H. Chitwood, Kenneth S. Gunasekera, Valeriu Crudu, Alexandru Codreanu, Nelly Ciobanu +5 more

An End-to-End Integrated Clinical and CT-Based Radiomics Nomogram for Predicting Disease Severity and Need for Ventilator Support in COVID-19 Patients: A Large Multisite Retrospective Study

Frontiers in Radiology(2022)10.3389/fradi.2022.781536

N/A

0DataRank · unranked

3 citations

Mehdi Alilou, Amogh Hiremath, Amit Gupta, Kaustav Bera, Jennifer Furin +8 more

Caring for Adolescents and Young Adults With Tuberculosis or at Risk of Tuberculosis: Consensus Statement From an International Expert Panel

Journal of Adolescent Health(2023)10.1016/j.jadohealth.2022.10.036

N/A

0DataRank · unranked

30 citations

Patricia M. Waterous, Vivian Faith Atieno, Sarah Bernays, Yaroslava Bondarenko, Andrea T. Cruz +28 more

Standards for clinical trials for treating TB

The International Journal of Tuberculosis and Lung Disease(2023)10.5588/ijtld.23.0341

N/A

0DataRank · unranked

5 citations

Jane Greig, J.-W. C. Alffenaar, Gail Brenda Cross, C. R. Cousins, Catherine Berry +35 more

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis: a mathematical modeling analysis

medRxiv(2023)10.1101/2023.07.28.23293104

N/A

0DataRank · unranked

0 citations

Fayette Klaassen, Sedona Sweeney, Jennifer Furin, Molly F. Franke, Reza Yaesoubi +7 more

Using risk prediction models to inform personalized, cost-effective treatment recommendations

medRxiv(2025)10.1101/2025.08.07.25333118

N/A

0DataRank · unranked

0 citations

Molly F. Franke, Carole D. Mitnick, Nelly Ciobanu, Valeriu Crudu, Jennifer Furin +3 more

Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations

American Journal of Respiratory and Critical Care Medicine(2020)10.1164/rccm.202002-0264ed

N/A

0DataRank · unranked

7 citations

Jennifer Furin, Sean Wasserman

“Six months is a lot of time to lie”: Anticipated stigma, disclosure and treatment preferences among participants in a tuberculosis therapeutic trial

Research Square(2025)10.21203/rs.3.rs-8277920/v1

N/A

0DataRank · unranked

0 citations

Cecilia Kanyama, Francis Makiya, John Metcalfe, Charity Potani, Kimberly K. Scarsi +3 more

Drug-Resistant Tuberculosis

Infectious Disease Clinics of North America(2020)10.1016/j.idc.2020.06.001

N/A

0DataRank · unranked

23 citations

Sebastian G. Kurz, Charles M. Bark, Robert A. Bonomo, Jennifer Furin, Khalid M Dousa

Nanotechnology approaches for global infectious diseases

Nature Nanotechnology(2021)10.1038/s41565-021-00866-8

N/A

0DataRank · unranked

506 citations

Malvika Verma, Paramesh Karandikar, Jennifer Furin, Robert Langer, Giovanni Traverso +1 more